MVEC’s CDIC social media poll: Results

At the recent पब्लिक हेल्थ एसोसिएशन ऑफ़ ऑस्ट्रेलिया (PHAA) Communicable Diseases & Immunisation Conference, MVEC invited conference attendees to answer a poll on our Instagram account (@mvecau) about their vaccine education experiences on social media. 

We learnt that: 

  • all respondents had seen vaccine misinformation or disinformation on social media 
  • all who work with patients had had a patient raise concerns based on something they viewed on social media 
  • most (88%) had learnt something about vaccines from an evidence-based, reliable social media account 
  • most (93%) believe social media has a place in vaccine education. 

The misinformation topic most respondents would like to see addressed by evidence-based social media creators is conspiracies.

Thank you so much to everyone who responded to the poll!


Kids Health Info: The 2026 flu update with Dr Nigel Crawford (podcast)

MVEC Director Prof Nigel Crawford was recently a guest on the Royal Children’s Hospital’s Kids Health Info podcast. 

Prof Crawford is the Director of SAEFVIC (Victorian safety reporting service) and MVEC, as well as medical head of the Royal Children’s Hospital Immunisation Service. 

Listen now

एमवीईसी: इन्फ्लुएंजा


Australian Islamic Medical Association: Flu vaccination guidance

The Australian Islamic Medical Association (AIMA) offers helpful guidance on influenza vaccination which address the permissibility of the nasal influenza vaccine containing porcine gelatine.  

According to AIMA, the vaccine containing porcine gelatine is permissible (halal) to use. The non-porcine injectable vaccine is available for families who prefer an alternative.

AIMA: Flu vaccination guidance

एमवीईसी: इन्फ्लुएंजा


Immunisation workshop in Mongolia

MVEC Director Prof Nigel Crawford and Education Nurse Coordinator Rachael McGuire recently travelled to Mongolia as part of a workshop with Mongolia’s National Immunization Technical Advisory Group (NITAG) and Ministry of Health.

Facilitating with colleagues from Murdoch Children’s Research Institute and the University of Melbourne, the 5-day program focused on NITAG strengthening, optimising न्यूमोकोकल prevention and response, health economics, vaccine safety, and communication. 

The international collaboration and support for evidence-based immunisation policy was a wonderful way to celebrate World Immunization Week! We look forward to the ongoing collaboration and continued learning. 

This project was supported by the Gates Foundation. Thank you to UNICEF for the invitation.


अद्यतित टीकाकरण संदर्भ पृष्ठ: इन्फ्लुएंजा

MVEC’s influenza reference page has been updated to include the latest recommendations and advice for the 2026 season. This includes a summary of vaccine brand for use in each age group as well as commonly asked questions.

Annual influenza vaccination is recommended for everyone aged 6 months and older. Influenza infection can cause a spectrum of symptoms, from mild cough and cold features to systemic illnesses with multiple complications. Pregnant women, children under 5 years, those aged over 65 years, people with underlying medical conditions, and Aboriginal and Torres Strait Islander peoples carry the highest rates of morbidity and mortality within Australia.

एमवीईसी: इन्फ्लुएंजा

(NB: translated versions of the updated influenza reference page will be available soon)


Benchmarque Group: Launceston immunisation seminar

Register now for Benchmarque Group’s 1-day immunisation seminar to be held in Launceston on 15 April 2026.

Learn more and register on the Benchmarque Group event page. 


SKAI: Talking with parents about human papillomavirus (HPV) vaccination

This recently published conversation guide aims to help immunisation providers engage confidently with parents and carers about the importance of timely human papillomavirus (HPV) vaccination.

Sharing Knowledge About Immunisation (SKAI): Talking with parents about human papillomavirus (HPV) vaccination 

To learn more about HPV, visit MVEC: HPV. 


TGA: 2026 Seasonal Influenza Vaccines

On 4 March, the Therapeutic Goods Administration (TGA) published its 2026 Seasonal Influenza Vaccines report. 

The report covers the 2026 seasonal influenza vaccines, with information on vaccines by age group, vaccine ingredients and co-administration. 

For more information, visit एमवीईसी: इन्फ्लुएंजा.


एमवीईसी के बारे में

मेलबोर्न वैक्सीन एजुकेशन सेंटर (एमवीईसी) एक शैक्षिक वेबसाइट है, जिसे स्वास्थ्य सेवा पेशेवरों और जनता के सदस्यों दोनों के लिए अद्यतित टीकाकरण जानकारी प्रदान करने के उद्देश्य से विकसित किया गया है। हम मर्डोक चिल्ड्रन्स रिसर्च इंस्टीट्यूट (MCRI), एक शोध संगठन पर आधारित हैं, और SAEFVIC (समुदाय में टीकाकरण के बाद प्रतिकूल घटनाओं की निगरानी), विक्टोरियन वैक्सीन सुरक्षा सेवा से संबद्ध हैं।